01 1Agno Pharma
01 1CARMUSTINE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-19
Pay. Date : 2017-04-13
DMF Number : 30184
Submission : 2017-03-24
Status : Active
Type : II
20
Agno Pharma, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARMUSTINE USP, with a corresponding US DMF Number 30184.
Remarkably, this DMF maintains an Active status since its submission on March 24, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 19, 2017, and payment made on April 13, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
